Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Operations (Unaudited)

v2.4.0.8
Consolidated Statements of Operations (Unaudited) (USD $)
3 Months Ended 9 Months Ended 160 Months Ended
Sep. 30, 2013
Sep. 30, 2012
Sep. 30, 2013
Sep. 30, 2012
Sep. 30, 2013
Statements Of Operations [Abstract]          
Revenue               
Operating expenses:          
Research and development, net of reimbursements 778,232 1,677,301 2,373,200 2,723,459 28,793,719
General and administrative 830,730 722,037 2,730,233 1,520,221 27,235,208
Depreciation and amortization expense    112    429 3,262,462
Loss on disposition of equipment       4,122    554,308
Total operating expenses 1,608,962 2,399,450 5,107,555 4,244,109 59,845,697
Loss from operations (1,608,962) (2,399,450) (5,107,555) (4,244,109) (59,845,697)
Other income (expense):          
Interest expense (1,299) (318,623) (2,508) (952,241) (1,967,215)
Gain on extinguishment of liability             260,000
Change in fair value - derivative liabilities 189,348 (294,381) 216,112 (287,604) 915,498
Total other income (expense) 188,049 (613,004) 213,604 (1,239,845) (791,717)
Net loss $ (1,420,913) $ (3,012,454) $ (4,893,951) $ (5,483,954) $ (60,637,414)
Net loss per common share - basic and diluted $ (0.06) $ (3.76) $ (0.22) $ (6.84)  
Weighted average number of common shares outstanding - basic and diluted 23,601,895 801,799 22,401,711 801,799